To bNAb or Not to bNAb? The case for broadly neutralizing antibodies

Join AVAC and partners for a conversation to explore the potential role of bNAbs in prevention, our current status in the field, and key issues to consider in HIV vaccine research.

Panelists: Slim Karim, CAPRISA, Pervin Anklesaria, Bill & Melinda Gates Foundation, Khadija Richards, Wits RHI, Huub Gelderblom, HIV Vaccine Trials Network (HVTN)
Hosted By: Mitchell Warren, AVAC and Stacey Hannah, AVAC